These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y, Liang L, Wang X, Wang J, Zhang X, Zhang Q. J Control Release; 2011 Jun 30; 152(3):402-10. PubMed ID: 21435361 [Abstract] [Full Text] [Related]
6. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Ramezani M, Khoshhamdam M, Dehshahri A, Malaekeh-Nikouei B. Colloids Surf B Biointerfaces; 2009 Aug 01; 72(1):1-5. PubMed ID: 19395245 [Abstract] [Full Text] [Related]
7. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes. Hatakeyama H, Akita H, Ishida E, Hashimoto K, Kobayashi H, Aoki T, Yasuda J, Obata K, Kikuchi H, Ishida T, Kiwada H, Harashima H. Int J Pharm; 2007 Sep 05; 342(1-2):194-200. PubMed ID: 17583453 [Abstract] [Full Text] [Related]
9. [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides]. Chen HL, Liang WQ, Shao JB, Chen Z. Yao Xue Xue Bao; 2004 Jan 05; 39(1):72-6. PubMed ID: 15127587 [Abstract] [Full Text] [Related]
15. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models. Yin X, Chi Y, Guo C, Feng S, Liu J, Sun K, Wu Z. Pharm Res; 2017 Oct 05; 34(10):2172-2184. PubMed ID: 28726003 [Abstract] [Full Text] [Related]
16. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. Abu Lila AS, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H. J Control Release; 2009 Jul 01; 137(1):8-14. PubMed ID: 19285528 [Abstract] [Full Text] [Related]
17. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. Ishida T, Atobe K, Wang X, Kiwada H. J Control Release; 2006 Oct 27; 115(3):251-8. PubMed ID: 17045355 [Abstract] [Full Text] [Related]
18. PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells. Dai W, Yang T, Wang X, Wang J, Zhang X, Zhang Q. J Drug Target; 2010 May 27; 18(4):254-63. PubMed ID: 19824864 [Abstract] [Full Text] [Related]
19. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors. Szala S, Missol E, Sochanik A, Strozyk M. Gene Ther; 1996 Nov 27; 3(11):1026-31. PubMed ID: 9044744 [Abstract] [Full Text] [Related]
20. A physicochemical characterization of the interaction between DC-Chol/DOPE cationic liposomes and DNA. Rodríguez-Pulido A, Ortega F, Llorca O, Aicart E, Junquera E. J Phys Chem B; 2008 Oct 02; 112(39):12555-65. PubMed ID: 18729499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]